Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(15 sites)

United States

Central Research Associates, LLC dba Flourish Research, Birmingham, Alabama

Hope Clinical Research, Canoga Park, California

Ark Clinical Research, Long Beach, California

Paradigm Clinical Research Centers, LLC, San Diego, California

Southwest General Healthcare Center, Fort Myers, Florida